*Some Market data delayed by 15 mins.

Ventyx Biosciences, Inc. Common Stock

Symbol: VTYX (NASDAQ)
0.00 ▼ (-100.00%) -3.110

Company Description:
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Key Stats
  • Today's Open: $0
  • Today's High: $0
  • Today's Low: $0
  • Today's Volume: 0
  • Yesterday Close: $3.11
  • Yesterday High: $3.18
  • Yesterday Low: $2.965
  • Yesterday Volume: 1.16M
  • Last Min Volume: 0
  • Last Min High: $0
  • Last Min Low: $0
  • Last Min VWAP: $0
Company Profile
  • Name: Ventyx Biosciences, Inc. Common Stock
  • Website: https://www.ventyxbio.com
  • Listed Date: 2021-10-21
  • Location: SAN DIEGO, CA
  • Market Status: Active
  • CIK Number: 0001851194
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $215.71M
  • Round Lot: 100
  • Outstanding Shares: 71.31M
  • Asset Type: CS
RECENT FILINGS FOR VTYX
Filing Date Filing Type Format
2025-08-14 SCHEDULE 13G/A View
2025-08-07 10-Q View
2025-08-07 8-K View
2025-07-16 SCHEDULE 13G/A View
2025-06-17 8-K View
2025-06-10 8-K View
2025-06-06 4 View
2025-06-06 4 View
2025-06-06 4 View
2025-06-06 4 View
2025-06-06 4 View
2025-05-30 SCHEDULE 13G View
2025-05-16 4 View
2025-05-16 4 View
2025-05-15 SCHEDULE 13G/A View
2025-05-15 SCHEDULE 13G/A View
2025-05-08 10-Q View
2025-05-08 8-K View
2025-04-23 ARS View
2025-04-23 DEFA14A View
Latest News on VTYX

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.